Advertisement
Advertisement
June 12, 2025
Viz.ai’s Viz Subdural Plus Cleared for Quantifying Collections of Subdural Hemorrhages
June 12, 2025—Viz.ai announced it has received FDA 510(k) clearance for Viz Subdural Plus, a comprehensive solution for quantifying the size of collections like subdural hemorrhages (SDH) in the subdural space on noncontrast CT images.
Viz.ai stated that the Viz Subdural Plus module is designed to support clinical decision-making by automatically labeling subdural collections and reporting measurements, including volume, thickness, and midline shift. The software is available as part of the Viz.ai One platform, noted the company.
“Viz Subdural Plus introduces a new level of precision in diagnosing and monitoring subdural hemorrhage,” commented David J. Altschul, MD, in the company’s press release. “Having automated volume and max thickness measurements at our fingertips allows us to make faster, more informed treatment decisions—especially critical in managing elderly patients or those on anticoagulants.”
Dr. Altschul, who is Division Chief Cerebrovascular Neurosurgery at Montefiore Health System in New York, New York, added, “As we increasingly turn to minimally invasive options like middle meningeal artery embolization to reduce recurrence, tools like Viz Subdural Plus are essential to guiding timely and effective treatment.”
Advertisement
Advertisement
